Term
|
Definition
- hypertension, sedative, opioid withdrawal
- centrally acting sympatholytic
- α-2 agonist = ↓ cAMP = inhibitory
- can also ↓ aqueous humor in the eye to ↓ intraocular pressure
- causes ↓ ACh release ➞ ↓ M3 activation in GI ➞ ↓ GI motility (constipation or treat diarrhea
- α2 agonist in respiratory ➞ ↓ respiration
- ↓ NE in CNS = ↓ SNS and ↑ PSNS = ↓ CO + PVR
|
|
|
Term
|
Definition
- hypertension, heart failure + excessive tachycardia, angina, arrhythmia
- non-selective β-blocker
- ↓ HR and CO
- b/c ↓ HR ➞ vasoconstriction of organ and skin
- used frequently
- also causes: ↓ secretion in eye, contraction of smooth muscle, and vasoconstriction in skeletal muscle
- toxicities are with β2 blockade (asthma)
|
|
|
Term
|
Definition
- hypertension, heart failure + excessive tachycardia, angina, arrhythmia
- selective β1-blocker
- block β1 in heart = ↓ CO
- b/c ↓ HR body compensates ➞ vasoconstriction
- block β1 in juxta-glomerular of kidney = ↓ renin release = ↓ PVR
- also causes: ↓ secretion in eye
|
|
|
Term
|
Definition
- hypertension
- selective α1-blocker
- block α1 in arterioles and venules = relax blood vessels
- body compensates with ↑ HR and ↑ renin = may need diuretics or β-blockers too
- also causes: relaxation of dilator muscle, ↑ secretion in eye, relaxation of sphincters, relaxation of pilomotor muscles
- toxicity = rare and mild (dizziness and headache)
|
|
|
Term
|
Definition
- hypertension
- nitric oxide donor
- used in emergencies (short-acting)
- toxicities = hypotension and cyanide accumulation
|
|
|
Term
|
Definition
- hypertension, angina, arrhythmia
- calcium channel blocker
- inhibits calcium influx into atrial smooth muscle cells ➞ relaxation ➞ vasodilation
- toxicity = bradycardia
|
|
|
Term
|
Definition
- hypertension, mild heart failure, left ventricular dysfunction (no edema)
- ACE inhibitor
|
|
|
Term
|
Definition
- hypertension, mild heart failure, left ventricular dysfunction (no edema)
- AT1 receptor blocker
- effectiveness similar to ACE inhibitor
|
|
|
Term
|
Definition
- hypertension, mild heart failure, heart failure + edma
- thiazide diuretic
- inhibit NaCl transport in distal convoluted tubule = ↑ NaCl in urine = ↑ H2O in urine = ↓ blood volume = ↓ BP
- toxicities: hypokalemia, gout, dehydration
|
|
|
Term
|
Definition
- hypertension
- loop diuretic
- inhibits cotransport of Na+, K+, and Cl- = inhibit NaCl reabsorption inhibited
- severe hypertensino and pulmonary edema
- toxicities: same as hydrochlorotriazide, and does-dependent ototoxicity (hearing loss)
|
|
|
Term
|
Definition
- congestive heart failure + atrial fibrillation or enlarged/dysfunctional left ventricle
- cardiac glycoside
- inhibits Na+/K+ ATPase
- direct effect: ↑ Na+ inside cell ➞ ↓ Ca2+ efflux out of cell ➞ ↑ intracellular Ca2+ ➞ ↑ interaction between actin + myosin ➞ ↑ cardiac contractility (strengthen output)
- indirect effect: ↑ PSNS and ↓ SNS activity from improved circulation ➞ ↓ baroreceptor activation (↓ rate and how hard heart has to work)
- therefore ↑ force and ↓ rate of contraction
- toxicities: arrhythmia (people with low K+) ➞ tachycardia and fibrillation, Quinidine reduces clearance, GI toxicities (anorexia, nausea, vomiting, and diarrhea)
|
|
|
Term
|
Definition
- angina
- nitrate goup converted to NO ➞ ↑cGMP ➞ relaxation of smooth muscle ➞ vasodilation (and other tissues ie. bronchioles)
- effects = ↓ venous return, ↓ PVR, dilation of coronary arteries ➞ ↓ O2 requirements and ↑ O2 delivery
- toxicities: hypotension, tachycardia (baroreceptore reflex), headaches, and when used with sildenafil
|
|
|
Term
|
Definition
- arrhythmia (all types)
- Na+ channel blocker
- prolongs Na+ channel in inactive phase ➞ subsequent stimulation of Na+ is delayed
- long-term treatment
|
|
|
Term
|
Definition
- arrhythmia
- ventricular tachycardia/fibrillation
- emergency situations
- same mechanism as Quinidine
|
|
|
Term
|
Definition
- arrhythmias
- K+ channel blocker
- prolongs action potential duration ➞ delays time for next AP
- also effects β-receptors + Na+/Ca+ channels
- most common for atrial fibrillations, ventricular tachycardia)
|
|
|
Term
|
Definition
- mild-moderate Alzheimer’s
- Acetylcholine esterase inhibitor
- inhibit breakdown of ACh
- side effects = similar to peripheral acting AChE inhibitors (primarily autonomic)
|
|
|
Term
|
Definition
- precursor to dopamine, norepinephrine, epinephrine
- can ↑ dopamine levels in brain
- converted to dopamine by L-amino acid dexarboxylase (DDC)
- side effects = hypotension, arrhythmias, nausea, disturbed respiration, hair loss, confusion, extreme emotions (ie. anxiety), insomina, narcolepsy
|
|
|
Term
|
Definition
- Parkinsons
- dopamine agonist (D2, D3, D4 receptors)
|
|
|
Term
|
Definition
|
|
Term
|
Definition
- Parkinsons
- antimuscarinic
|
|
|
Term
|
Definition
- psychosis
- butyrophenone derivative
- receptor antagonist: D2 > α1 > D4 > 5-HT2a > D1 > H1
- side effects: parkinson-like symptoms (D2 blockade), hypotension (α1 blockade)
|
|
|
Term
|
Definition
- psychosis
- atypical receptor antagonist: 5-HT2a > H1 > D4 > D2 > α1 > D1
- side effects: sedation (5-HT2a blockade)
|
|
|
Term
|
Definition
- bipolar (most effective against mania)
- may ↑ serotonin and ↓ NE + dopamine neurotransmission
- lithium ➞ ↓ in precursors for IP2 and DAG synthesis ➞ ↓ IP3 + DAG when receptors linked to second messengers are activated (ie. muscarinic, α1, 5-HT2a receptors)
|
|
|
Term
|
Definition
- depression
- tricyclic antidepressant
- ↓ NE and serotonin re-uptake
- adverse effects b/c = blocks cardiac sodium channels and is antagonist at muscarinic, histaminic, and α1 receptors
|
|
|
Term
|
Definition
- depression
- weak inhibitor of re-uptake and stimulates release of NE and dopamine
- doesnt block histaminic, adrenergic, or muscarinic receptors
- increases dopamine levels (not good in psychosis)
|
|
|
Term
|
Definition
- depression, anxiety, OCD, bulemia
- most widely prescribed
- serotonin re-uptake inhibitor
- side effect: insomnia, sexual dysfunction, ↑ suicide rates in children, inhibits CYP2D6 (overdose when taken with other antidepressants)
|
|
|
Term
|
Definition
- depression
- MAO inhibitor
- not selective for MAO-A or MAO-B therefore ↑ NE, serotinin, and dopamine
- only used when tricyclic don’t work
- no significant side-effects when taken on their own
- when taken with a tyarmine-containing food or with CNS stimulants ➞ hypertensive crisis
- do not take with any seroternergic agents (SSRIs, SNRIs, tricyclics) ➞ serotonin syndrome
- sympatheticomimetics contradicted in people taking MAOIs
|
|
|
Term
|
Definition
- anxiety, ethanol withdrawal
- a benzodiazepine
- all metabolites are active
- enhances GABA neurotransmission by binding to GABAa receptor at different site and ↑ binding frequency of GABA-mediated opening of Cl- channel
- enhance Cl- conductance ➞ ↑ inhibition of many neurons in many brain regions
|
|
|
Term
|
Definition
- anxiety
- a barbiturate
- enhances GABA neurotransmission by binding GABAa at different site and ↑ duration of opening of GABA-mediated Cl- channels
- at high doses can directly activate GABAa and inhibit glutamate receptors and high-frequency sodium channels (lower therapeutic margin)
- also ↑expression of some cytochrome P450 enzymes
|
|
|
Term
|
Definition
- a sedative-hypnotic
- ↓ membrane excitability, ↑GABAa, ↓NMDA activation ➞ dose-dependent CNS depression
- also: ↓ myocardial contractility, ↓ anxiety, slurred speech, impaired judgment
- toxicicity: CNS and respiratory depression
- chronic use: fatty liver ➞ hepatitis ➞ cirrhosis ➞ liver failure, pancreatitis, gastritis, malnutrition
|
|
|
Term
|
Definition
- metabolizes ➞ formaldehyde ➞ formic acid
- formic acid accumulation causes blindness
- treat with ethanol (compete for alcohol dehydrogenase)
|
|
|
Term
|
Definition
- drug of abuse
- opioid
- presynaptic: binds to μ receptor linked to G-protein ➞ ↓ Ca+ ➞ ↓ release of neurotransmitters (GABA and glutamate)
- postynaptic: binds to μ receptor ➞ ↑ K+ efflux ➞ inhibits postsynaptic renurons (more negative and harder to activate)
- overdoes: respiratory depression ➞ coma ➞ death
- methadon and chlonidine to treat withdrawal
|
|
|
Term
|
Definition
- drugs of abuse
- stimulant
- highly addictive
- ↓ re-uptake of NE, dopamine, and serotonin ➞ ↑ alertness and euphoria
- side-effects: psychosis, delusions, excess SNS activity
- overdoes: intracranial hemorrhage, stroke, seizure, arrhythmia, heart attack, hyperthermia, coma, death
|
|
|
Term
|
Definition
- drug of abuse
- stimulant
- ↑ release of NE, dopamine, and serotonin ➞ ↑ alertness and euphoria
- side-effects: psychosis, delusions, excess SNS activity
- overdose: hyperthermia, serotonin syndrome, seizures, neuronal damage
|
|
|
Term
LSD (lysergic acid diethylamide), mescaline, psilocybin |
|
Definition
- drug of abuse
- 5-HT2a partial agonist
- causes visual illusions and perceptual distortion
- side effects: panic, psychosis, strong uterine contractions
|
|
|
Term
|
Definition
- drug of abuse
- NMDA receptor antagonist
- causes visual illusions and perceptual distortion
- side effects: panic, psychosis
- can be fatal in overdose
|
|
|
Term
|
Definition
- drug of abuse, cancer, glaucoma, AIDS
- THC binds cannaboid receptor (CB1 and CB2) linked to G-protein ➞ inhibits GABA or glutamate release
- initial effect: euphoria, laughter, altered sense of time
- secondary effect: relaxation, introspection, ↓ reaction time, ↓ learning/memory
- side effects: can causes paranoia, anxiety, hallucinations
- chronic: bronchitis, lung cancer
|
|
|
Term
|
Definition
- sedative and analgesic
- α-2 agonists
- stimulate α2 receptor ➞ open K+ channels ➞ inhibit neurotransmitter release in brain
- causes: sedation, analgesia, hypotension, muscle relaxing, ↓ O2 exchange
|
|
|
Term
|
Definition
- sedative-hypnotic, muscle relaxant
- benzodiazepine
- enhances GABA neurotransmission by binding to GABAa receptor at different site and ↑ binding frequency of GAMA-mediated opening of Cl- channel
- enhance Cl- conductance ➞ ↑ inhibition of many neurons in many brain region
- little effect on cadiovascular system and little respiratory depressant at therapeutic doses
- side effect: drowsiness and confusion, CNS depression with alcohol use
- adverse effects reversed by flumazenil (GABAa antagonist)
|
|
|
Term
|
Definition
- analgesic, sedative, cough suppression
- opioid
- stimulate pre-synaptic μ-opioid receptor in CNS ➞ inhibits GABA and glutamate release ➞ intense analgesia
- side effects: constipation, nausea, urine retension, dose-dependent resp depression (death in overdose)
|
|
|
Term
|
Definition
- good analgesia but weaker effect at μ receptor (partial agonist)
- opioid
|
|
|
Term
|
Definition
- reverse opioid overdose, opioid effects after surgery, or for shocky patients
- opioid receptor antagonist
|
|
|
Term
|
Definition
- 1000-8000 X more potent than morphine
- opioid
- used in wild-life
- reversal agent = M5050
|
|
|
Term
|
Definition
- induction agent and short term anesthesia
- barbituate
- enhances GABA neurotransmission by binding GABAa at different site and ↑ duration of opening of GABA-mediated Cl- channels
- at high doses can directly activate GABAa and inhibit glutamate receptors and high-frequency sodium channels (lower therapeutic margin)
- does-dependent CNS but partial does causes excitement, less smooth recovery (esp if multiple doses)
- effects: does-dependent resp depression, 30 second apnea, hypotension, and extravascular damage
|
|
|
Term
|
Definition
- induction agent and short procedures
- facilitates effect of GABA at GABAa in brain ➞ inhibits action potentials
- smooth induction without excitement stage, rapid smooth recovery
- adverse effects: dose-dendent resp depression, 60 second apnea, hypotension, diarrhea
|
|
|
Term
|
Definition
- dissociative anasthetic and moderate analgesic
- inhibits NMDA and GABA
- inhibits perception of signals associated with senses without totally abolishing consciousness
- dissociative = open eyes, swallow, can hear, intense muscle rigidity, hallucinations, disconnected from surroundings and pain
- adverse effects: hypo- or hyperthermia, mood alterations, floating, vivid dreams, hallucinations, ↑ BP, minimal resp depression, can precipitate seizures, excitement if used alone
|
|
|
Term
|
Definition
- inhaled anesthetic
- halogenate hydrocarbon
- facilitates GABA at low concentrations and directly activates GABA receptors at high concentrations ➞ opens Cl- channels ➞ inhibits APs
- adverse effects: liver damage (25% metabolism), ↓ CO + EP release + ↑ sensitivity to EP ➞ arrhythmias, hypothermia, malignant hyperthermia (inherited disorder)
|
|
|
Term
|
Definition
- inhaled anesthetic
- halogenate hydrocarbon
- facilitates GABA at low concentrations and directly activates GABA receptors at high concentrations ➞ opens Cl- channels ➞ inhibits APs
- only 0.2% metabolized and low solubility in tissues ➞ less hepatic damage, less depression of CO, less potenet than halothane
- adverse effects: dose-dependent ↓ in BP and bad odour
|
|
|
Term
|
Definition
- inhaled anesthetic
- halogenate hydrocarbon
- facilitates GABA at low concentrations and directly activates GABA receptors at high concentrations ➞ opens Cl- channels ➞ inhibits APs
- less odour and even less soluble in tissues than isoflurane but slightly more metabolized
|
|
|
Term
|
Definition
- inhalant analgesic but not anesthetic
- weak CNS depressant
- used to decrease amount of other inhalants needed and increase speed of gas anesthetic uptake
- no respiratory depression and little cardiovascular effects
- can cause toxicity (rapid uptake of other inhalants), gas pockets in GI, and hypoxia
|
|
|
Term
|
Definition
- non-depolarizing neuromuscular blocker
- competitive antagonist of AChRs (Nm)➞ intense relaxation or paralysis of voluntary muscle (dose-dependent)
- prevents eye movement during ocular surgery
- rapid reversal with AChEs (neostigmine, edrophenium)
- adverse effects: can trigger histamine release, metabolized to laudacarium and can trigger seizures
- now use lisatracarium (less adverse effects)
|
|
|
Term
|
Definition
- bind receptor on cytoplasmic surface of voltage-sensitive Na+ channels and block pore ➞ Na+ cant enter cell ➞ inhibits APs in axons
- small fibers (ie pain) are blocked at lower concentrations ➞ motor fibers blocked last
- adverse effects: dose-dependent drowsiness ➞ excitations (seizures), ↓ excitability of myocardium ➞ AV block, arrhythmias, high concentrations = cardiac arrest, when with vasoconstrictor (ie. EP) ➞slow delayed healing and removal of drug ➞ prolongs action and doubles duration (toxicity)
|
|
|
Term
|
Definition
- local anesthetic, arrhythmia (ventricular tachycardia/fibrillation)
- various administrations
- overdose = drowsiness or seizures ➞ muscle twitching and possibly cardiac arrest ➞ death
- emergency situations
- same mechanism as quinidine
|
|
|
Term
|
Definition
- local anesthetic
- slower onset but greater duration
- greater CVS toxicity
|
|
|
Term
|
Definition
- local anesthetic
- S-enantomer of Bupivacaine
- doesnt distribute to CNS and heart ➞ less CVS toxicities
|
|
|
Term
|
Definition
- local anesthetic
- least irritating for eye
|
|
|